跳至主要内容
临床试验/NCT04201730
NCT04201730已完成不适用

A Single Center, Open, Randomized Clinical Trial:Study on the Efficacy and Safety of Enhanced Recovery After Surgery (ERAS)in Gastrointestinal Cancer

Huashan Hospital1 个研究点 分布在 1 个国家目标入组 356 人开始时间: 2019年12月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
356
试验地点
1
主要终点
Hospitalization Days

研究概览

简要总结

At present, there are more and more reports about enhanced recovery after surgery(ERAS)in China, but there is no ERAS treatment standard for gastrointestinal cancer, and there are many factors limiting the development of ERAS. In recent years, due to the development of minimally invasive technology, the establishment of evidence-based medicine model and the development of MDT, it makes a good solid foundation for the clinical application of ERAS. The implementation of ERAS requires the cooperation of surgeons, anesthesia management, nursing, rehabilitation and other teams. As an individualized treatment mode, ERAS focuses on the optimization of treatment for different individuals in order to acquire the best benefit of patients. Therefore, the concept of ERAS is still in the process of continuous improvement and development in China, hoping to explore the Chinese ERAS clinical pathway for gastrointestinal cancer. The purpose of this study is to optimize the clinical pathway of ERAS in the perioperative period of gastrointestinal cancer, and to evaluate the effectiveness and safety of ERAS in gastrointestinal cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sign the informed consent
  • Preoperative pathology confirmed gastric cancer or colorectal cancer
  • Age: 18-70 years, men or women
  • According to NCCN guidelines, it is not Stage IV tumor
  • Perform radical gastrectomy or radical colon cancer surgery (CME) or radical rectal cancer surgery (TME);
  • ASA I-III
  • Receive no radiotherapy or chemotherapy before operation
  • The subjects can describe the symptoms objectively and keep the follow-up plan

排除标准

  • Preoperative pathology confirmed no gastric cancer / no colorectal cancer (such as rectal neuroendocrine tumor, lymphoma, etc.)
  • Stage IV or Radical resection can't be performed
  • Emergency operation
  • Can't cooperate with clinical data collection
  • General condition is intolerable to operation
  • Serious diseases, including heart function ≥ level II, respiratory function insufficiency, liver and kidney function insufficiency, and blood system diseases
  • Patients participate in other clinical trials at the same time
  • Pregnant or perinatal women
  • Other malignant tumors
  • History of mental illness
  • Had a history of severe trauma within 4 weeks before admission
  • Less than 6 months after other level 4 operations

结局指标

主要结局

Hospitalization Days

时间窗: Postoperative up to 2 weeks

The time to first flatus

时间窗: Postoperative 7 days

Time of getting out of bed after operation

时间窗: Postoperative 7 days

次要结局

  • Expenses on medical treatment, medicine and hospitalization(On discharge, Postoperative up to 2 weeks)
  • Incidence of postoperative complications(Postoperative 3 months、6 months、1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianbin Xiang

Professor

Huashan Hospital

研究点 (1)

Loading locations...

相似试验

Study on the Efficacy and Safety of Enhanced... | 临床试验